Evidence map›Paper›PMID 35887336›Full record

ReviewInternational journal of molecular sciences2022

Emerging Roles of the Iron Chelators in Inflammation.

Alessandra Di Paola, Chiara Tortora, Maura Argenziano, Maria Maddalena Marrapodi, Francesca Rossi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 8 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 8 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. The crosstalk between iron metabolism and immune tolerance in autoimmunity.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alessandra Di PaolaDepartment of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 4, 80138 Naples, Italy.
Chiara TortoraDepartment of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 4, 80138 Naples, Italy.
Maura ArgenzianoDepartment of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 4, 80138 Naples, Italy.
Maria Maddalena MarrapodiDepartment of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 4, 80138 Naples, Italy.
Francesca RossiDepartment of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 4, 80138 Naples, Italy.
University of Campania "Luigi Vanvitelli" · IT

Funding

University of Campania "Luigi Vanvitelli" VALERE19 "In-CHICAS"
6 · The paper itself

Abstract

Iron is a crucial element for mammalian cells, considering its intervention in several physiologic processes. Its homeostasis is finely regulated, and its alteration could be responsible for the onset of several disorders. Iron is closely related to inflammation; indeed, during inflammation high levels of interleukin-6 cause an increased production of hepcidin which induces a degradation of ferroportin. Ferroportin degradation leads to decreased iron efflux that culminates in elevated intracellular iron concentration and consequently iron toxicity in cells and tissues. Therefore, iron chelation could be considered a novel and useful therapeutic strategy in order to counteract the inflammation in several autoimmune and inflammatory diseases. Several iron chelators are already known to have anti-inflammatory effects, among them deferiprone, deferoxamine, deferasirox, and Dp44mT are noteworthy. Recently, eltrombopag has been reported to have an important role in reducing inflammation, acting both directly by chelating iron, and indirectly by modulating iron efflux. This review offers an overview of the possible novel biological effects of the iron chelators in inflammation, suggesting them as novel anti-inflammatory molecules.

Indexed as

Iron OverloadAnimalsBenzoatesDeferasiroxDeferiproneDeferoxamineInflammationIronIron Chelating AgentsMammalsPyridonesBenzoatesDeferasiroxDeferiproneDeferoxamineIronIron Chelating AgentsPyridonesanti-inflammatory propertiesdeferasiroxdeferipronedeferoxamineDp44mTeltrombopaginflammationironiron chelation

Identifiers

PMID35887336
PMCPMC9318075
OpenAlexW4286007955

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.